117 related articles for article (PubMed ID: 23200256)
1. Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor.
Giordanetto F; Wållberg A; Knerr L; Selmi N; Ullah V; Thorstensson F; Lindelöf Å; Karlsson S; Nikitidis G; Llinas A; Wang QD; Lindqvist A; Högberg G; Lindhardt E; Åstrand A; Duker G
Bioorg Med Chem Lett; 2013 Jan; 23(1):119-24. PubMed ID: 23200256
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.
Park JE; Ji WK; Jang JW; Pae AN; Choi K; Choi KH; Kang J; Roh EJ
Bioorg Med Chem Lett; 2013 Mar; 23(6):1887-90. PubMed ID: 23395659
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
[TBL] [Abstract][Full Text] [Related]
8. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and SAR study of T-type calcium channel blockers. Part II.
Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
12. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.
Gu SJ; Lee JK; Pae AN; Chung HJ; Rhim H; Han SY; Min SJ; Cho YS
Bioorg Med Chem Lett; 2010 May; 20(9):2705-8. PubMed ID: 20382529
[TBL] [Abstract][Full Text] [Related]
14. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Jang SJ; Choi HW; Choi DL; Cho S; Rim HK; Choi HE; Kim KS; Huang M; Rhim H; Lee KT; Lee JY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6656-62. PubMed ID: 24220170
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
[TBL] [Abstract][Full Text] [Related]
17. Lead discovery and optimization of T-type calcium channel blockers.
Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
[TBL] [Abstract][Full Text] [Related]
18. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY
Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437
[TBL] [Abstract][Full Text] [Related]
20. Biophysics and structure-function relationship of T-type Ca2+ channels.
Talavera K; Nilius B
Cell Calcium; 2006 Aug; 40(2):97-114. PubMed ID: 16777221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
